Amniotic Fluid Index: Complete Ultrasound Measurement Guide

The amniotic fluid index (AFI) is a semiquantitative ultrasound measurement that assesses amniotic fluid volume by dividing the uterus into four quadrants using the linea nigra as a vertical reference and the umbilicus as a horizontal reference, then measuring the deepest vertical pocket of amniotic fluid free of umbilical cord and fetal extremities in each quadrant. Normal AFI ranges from 8-18 cm, with values ≤ 5 cm indicating oligohydramnios and values ≥ 24 cm indicating polyhydramnios. Amniotic fluid volume reflects fetal wellbeing, placental function, and fetal renal function, with abnormalities associated with increased perinatal morbidity and mortality. Oligohydramnios affects 3-5% of pregnancies and is associated with intrauterine growth restriction (IUGR), placental insufficiency, fetal renal abnormalities, and increased risk of umbilical cord compression. Polyhydramnios affects 1-2% of pregnancies and is associated with maternal diabetes, fetal anomalies, multiple gestation, and increased risk of preterm labor and cord prolapse. Management strategies depend on underlying etiology, gestational age, and severity, ranging from close monitoring to delivery, with amnioinfusion sometimes used for severe oligohydramnios.

Physiology of Amniotic Fluid

Amniotic fluid is a complex dynamic fluid that changes throughout pregnancy:

Sources of Amniotic Fluid:

Amniotic Fluid Removal:

• Fetal swallowing: Primary mechanism of fluid removal
• Fetal respiration: Contributes to fluid turnover
• Membrane absorption: Some fluid absorbed across membranes

Amniotic Fluid Turnover:

• Early pregnancy: Low turnover rate
• Late pregnancy: High turnover rate, up to 500-1000 mL/hour
• Dynamic equilibrium: Balance between production and removal

Functions of Amniotic Fluid:

1. Fetal protection: Cushions fetus from trauma
2. Temperature regulation: Maintains constant temperature
3. Musculoskeletal development: Allows fetal movement
4. Lung development: Essential for normal lung growth
5. Umbilical cord protection: Prevents cord compression
6. Antimicrobial properties: Protects against infection

Amniotic Fluid Volume Throughout Pregnancy

Amniotic fluid volume normally follows a characteristic pattern:

Gestational Age-Specific Volumes:

Normal Pattern:

• Early pregnancy: Volume increases
• Mid-pregnancy (20-32 weeks): Peak volume
• Late pregnancy: Gradual decline (post-term: more rapid decline)

Measurement Technique

The AFI measurement follows a standardized technique:

Procedure:

1. Patient position: Supine with slight lateral tilt to avoid caval compression
2. Transducer orientation: Perpendicular to maternal abdomen and floor
3. Uterus division: Divided into four quadrants
   • Vertical reference: Linea nigra (midline)
   • Horizontal reference: Umbilicus
4. Measurement in each quadrant: Deepest vertical pocket of amniotic fluid
   • Exclusions: Umbilical cord, fetal extremities
   • Measurement: Vertical measurement in centimeters
5. Calculation: Sum of four quadrant measurements

Measurement Requirements:

• Deep vertical pocket: Must be at least 1 cm wide
• Free of cord: Cord should not be within the pocket
• Free of extremities: No fetal limbs in the pocket
• Vertical measurement: Must be vertical (not horizontal or oblique)
• Caliper placement: Inner edge to inner edge measurement

Normal Values

Standard Normal Ranges:

Alternative Measurement: Single Deepest Pocket (SDP)

• Normal: ≥ 2 cm x 1 cm
• Oligohydramnios: ＜ 2 cm x 1 cm
• Clinical use: Alternative to AFI, some studies suggest SDP may be superior

Controversy: AFI vs SDP

• Traditional approach: AFI (four-quadrant sum)
• Alternative approach: SDP (single deepest vertical pocket)
• Evidence: Several meta-analyses suggest SDP may be more specific for oligohydramnios with fewer false positives
• Current practice: Both methods used, AFI remains more common in clinical practice

Definition and Classification

Oligohydramnios refers to decreased amniotic fluid:

Classification by Severity:

Incidence:

• Overall: 3-5% of pregnancies
• Term pregnancies: 5-10%
• Preterm pregnancies: 1-3%

Etiology (Causes)

Maternal Causes:

• Placental insufficiency: Most common cause in third trimester
• Maternal hypertension: Chronic hypertension, preeclampsia
• Maternal hypovolemia: Dehydration, hemorrhage
• Medications: ACE inhibitors, ARBs (contraindicated in pregnancy)
• Premature rupture of membranes: PPROM (see below)

Fetal Causes:

• Intrauterine growth restriction: 30-40% of IUGR cases have oligohydramnios
• Fetal renal abnormalities: Bilateral renal agenesis (Potter syndrome), polycystic kidney disease, obstructive uropathy
• Fetal hypoxia: Placental insufficiency leading to fetal blood flow redistribution away from kidneys
• Fetal demise: Oligohydramnios develops after fetal death
• Post-term pregnancy: Declining amniotic fluid after 40-41 weeks

Placental Causes:

• Placental insufficiency: Decreased uteroplacental blood flow
• Placental abruption: May cause oligohydramnios
• Placenta previa: May be associated with oligohydramnios

Membrane Causes:

• Premature rupture of membranes (PPROM): Spontaneous rupture before labor
  • Diagnosis: History of fluid leakage, positive nitrazine test, ferning, AFI measurement
  • Management: Depends on gestational age

Clinical Significance and Risks

Maternal Risks:

• Increased risk of cesarean delivery: Due to fetal heart rate abnormalities
• Increased risk of cord compression: Due to decreased fluid cushioning
• Labor abnormalities: Increased risk of dysfunctional labor

Fetal Risks:

Management

General Principles:

• Identify underlying cause: Guide management based on etiology
• Assess gestational age: Management depends on gestational age
• Evaluate fetal status: Include growth assessment, Doppler studies, antenatal testing
• Determine severity: Guides intensity of monitoring

Management by Gestational Age:

Preterm (＜ 34 weeks):

• Identify cause: Detailed anatomic survey, evaluate for PPROM
• Close monitoring: Twice weekly NST, weekly AFI assessment
• Maternal hydration: Some evidence for oral or IV hydration increasing AFI
• Consider amnioinfusion: For severe oligohydramnios with pulmonary hypoplasia risk (controversial)
• Corticosteroids: If preterm delivery likely
• Timing of delivery: Individualized based on gestational age, severity, underlying etiology

Late Preterm (34-36 weeks):

• Increased monitoring: Daily or every other day NST, twice weekly AFI
• Maternal hydration: May be beneficial
• Delivery consideration: Often deliver at 36-37 weeks depending on etiology and severity
• Corticosteroids: Consider if delivery likely within 7 days

Term (≥ 37 weeks):

• Delivery typically recommended: Especially if severe or persistent
• Indications for delivery: Severe oligohydramnios (AFI ≤ 5), abnormal antenatal testing, underlying conditions (preeclampsia, IUGR)
• Timing: Usually within 24-48 hours depending on situation

Post-term (> 40-41 weeks):

• Increased surveillance: Twice weekly NST, AFI measurement twice weekly
• Delivery recommendation: Typically recommend delivery by 41-42 weeks if oligohydramnios present

Definition and Classification

Polyhydramnios refers to excessive amniotic fluid:

Classification by Severity:

Incidence:

• Overall: 1-2% of pregnancies
• Mild cases: Approximately 60-70% of polyhydramnios cases
• Severe cases: 10-15% of polyhydramnios cases

Etiology (Causes)

Idiopathic (Most Common):

• No identifiable cause: 50-70% of mild cases, 30-40% of all cases
• Benign course: Typically no adverse outcomes
• Spontaneous resolution: Often resolves as pregnancy progresses

Maternal Causes:

• Diabetes mellitus: 20-30% of diabetic pregnancies (poorly controlled)
  • Mechanism: Fetal polyuria due to maternal hyperglycemia
  • Management: Glycemic control, monitor for congenital anomalies
• Isoimmunization: Rh disease, other alloimmunization
• Multiple gestation: Twins, triplets (especially monozygotic)

Fetal Causes:

• Fetal anomalies: 10-20% of cases
  • GI obstruction: Esophageal atresia, duodenal atresia (unable to swallow fluid)
  • CNS abnormalities: Anencephaly (unable to swallow fluid)
  • Neuromuscular disorders: Fetal akinesia, myotonic dystrophy
  • Cardiovascular abnormalities: High-output states
  • Thoracic abnormalities: Pleural effusions, cystic adenomatoid malformation
• Fetal anemia: Hydrops fetalis
• Fetal infection: TORCH infections (especially parvovirus)
• Multiple gestation: Twin-twin transfusion syndrome (recipient twin)

Placental Causes:

• Chorioangioma: Large benign placental tumor
• Circumvallate placenta: Abnormal placental configuration

Clinical Significance and Risks

Maternal Risks:

Fetal Risks:

Management

General Principles:

• Identify underlying cause: Detailed anatomy survey, diabetes screening
• Assess severity: Determines management intensity
• Monitor for complications: Preterm labor, PPROM, cord prolapse
• Determine delivery planning: Mode and timing of delivery

Evaluation:

1. Detailed anatomical survey: Evaluate for fetal anomalies
2. Diabetes screening: If not already diagnosed
3. Maternal antibody screening: For isoimmunization
4. Fetal echocardiogram: If cardiac anomaly suspected
5. Genetic testing: If anomaly identified or high risk
6. Amniocentesis: If indicated (karyotype, infection studies)

Management by Severity:

Mild Polyhydramnios (AFI 24-30 cm):

• Usually idiopathic: No intervention typically needed
• Observe: Serial AFI measurements every 2-4 weeks
• Patient education: Report signs of preterm labor, PPROM
• Delivery planning: Usually routine obstetric delivery

Moderate Polyhydramnios (AFI 30-35 cm):

• Evaluate for cause: Detailed survey, diabetes screen
• Close monitoring: Serial AFI every 1-2 weeks
• Activity modification: May reduce activity
• Consider amnioreduction: For symptomatic patients (shortness of breath, significant discomfort)
• Delivery planning: Individualized based on etiology

Severe Polyhydramnios (AFI > 35 cm):

• Comprehensive evaluation: Detailed survey, fetal echo, genetic testing
• Frequent monitoring: Serial AFI weekly or more often
• Amnioreduction: Therapeutic removal of amniotic fluid via amniocentesis
  • Indication: Maternal respiratory compromise, significant discomfort, preterm labor
  • Procedure: Remove 1-2 liters of fluid slowly
  • Risks: PPROM, preterm labor, infection, abruption, placental separation
• Tocolytics: If preterm labor develops
• Corticosteroids: If preterm delivery likely
• Delivery planning: Individualized, often preterm delivery required

Delivery Considerations:

• Cesarean delivery: Often indicated for severe polyhydramnios
  • Indications: Malpresentation, prior classical cesarean, severe polyhydramnios, anomalous fetus
• Cord prolapse precautions: If rupture of membranes occurs
• Delivery timing: Individualized based on etiology, severity, gestational age

Premature Rupture of Membranes (PPROM)

PPROM is rupture of membranes before labor onset:

Diagnosis:

• History: Sudden gush or persistent leakage of fluid
• Physical exam: Sterile speculum exam, avoid digital exam
• Nitrazine test: Turns blue with amniotic fluid
• Ferning test: Amniotic fluid forms fern pattern on microscope slide
• AFI measurement: Oligohydramnios supports diagnosis

Management (Based on Gestational Age):

Multiple Gestation

Twins and Higher Order Multiples:

• Normal AFI: Different normal ranges for multiples (higher than singletons)
• Discordant fluid: May indicate TTTS (twin-twin transfusion syndrome)
  • Stuck twin: Donor twin with oligohydramnios (stuck against membrane)
  • Polyhydramnios: Recipient twin with polyhydramnios
• Management: Referral to maternal-fetal medicine, TTTS staging, possible laser surgery

Post-Term Pregnancy

Post-term (> 40-41 weeks):

• Normal decline: AFI normally decreases after 40 weeks
• Oligohydramnios risk: Increased risk of oligohydramnios
• Management: Twice weekly NST and AFI assessment, delivery by 41-42 weeks if oligohydramnios develops

What causes low amniotic fluid? The most common causes of oligohydramnios are placental insufficiency (often associated with intrauterine growth restriction and preeclampsia), premature rupture of membranes (PPROM), fetal renal abnormalities (such as bilateral renal agenesis or urinary tract obstruction), and post-term pregnancy. Less common causes include maternal dehydration, medications (especially ACE inhibitors), and maternal hypovolemia. Identifying the underlying cause is important for determining appropriate management.

Can low amniotic fluid be treated? Treatment depends on the underlying cause and gestational age. For mild cases related to placental insufficiency, close monitoring and maternal hydration (oral or IV) may be recommended. In cases of PPROM, management depends on gestational age and may include antibiotics, corticosteroids, and sometimes expectant management with close monitoring. Severe oligohydramnios at earlier gestational ages may be treated with amnioinfusion (infusion of fluid into the amniotic cavity), though this is controversial. At term, delivery is typically recommended for significant oligohydramnios.

What causes too much amniotic fluid (polyhydramnios)? Common causes of polyhydramnios include maternal diabetes (especially poorly controlled), multiple gestation (twins or more), fetal anomalies (especially gastrointestinal or neurological abnormalities that impair fetal swallowing), and fetal anemia. However, in 50-70% of mild cases, no specific cause is identified (idiopathic). More severe polyhydramnios is more likely to have an identifiable cause. Evaluation typically includes a detailed anatomical survey, diabetes screening, and sometimes additional testing.

Does having low or high amniotic fluid mean my baby will have problems? Not necessarily, but both conditions are associated with increased risks. Oligohydramnios increases risks including cord compression, fetal heart rate abnormalities, meconium aspiration, and in severe cases, pulmonary hypoplasia. However, many babies with oligohydramnios have good outcomes, especially when mild and identified near term. Polyhydramnios increases risks of preterm birth, cord prolapse, and is more often associated with fetal anomalies. However, mild idiopathic polyhydramnios often has normal outcomes. Each situation is individual, and your healthcare provider can discuss your specific risks and management.

How often should amniotic fluid be checked? Amniotic fluid is checked routinely during the anatomy scan (18-22 weeks) and during third-trimester growth scans in many practices. If oligohydramnios or polyhydramnios is identified, AFI may be monitored more frequently (weekly, twice weekly, or more often depending on severity). In high-risk pregnancies (IUGR, preeclampsia, diabetes, PPROM), AFI is often assessed with each ultrasound examination. The specific monitoring frequency depends on your individual situation and will be recommended by your healthcare provider.

• Amniotic fluid index (AFI) is measured by dividing the uterus into four quadrants and summing the deepest vertical pocket of amniotic fluid in each quadrant, with normal values ranging from 8-18 cm.

• Oligohydramnios (AFI ≤ 5 cm) affects 3-5% of pregnancies and is associated with increased risks of umbilical cord compression, fetal heart rate abnormalities, meconium aspiration, pulmonary hypoplasia (in severe early cases), and perinatal mortality.

• Polyhydramnios (AFI ≥ 24 cm) affects 1-2% of pregnancies and is associated with increased risks of preterm labor, premature rupture of membranes, cord prolapse, placental abruption, and perinatal mortality.

• Common causes of oligohydramnios include placental insufficiency (30-40% of IUGR cases), premature rupture of membranes (PPROM), fetal renal abnormalities, and post-term pregnancy.

• Common causes of polyhydramnios include maternal diabetes (20-30% of diabetic pregnancies), multiple gestation, fetal anomalies (10-20% of cases), and idiopathic causes (50-70% of mild cases).

• Management of oligohydramnios includes identifying the underlying cause, increased monitoring frequency (weekly to twice weekly), maternal hydration, and delivery timing based on gestational age and severity (often 34-37 weeks for moderate-severe cases, term for mild cases).

• Management of polyhydramnios includes evaluation for underlying causes (anatomical survey, diabetes screening), monitoring frequency based on severity, amnioreduction for severe symptomatic cases, and individualized delivery planning often favoring cesarean delivery.

• Single deepest pocket (SDP) measurement is an alternative to AFI that may be more specific for oligohydramnios with fewer false positives, though AFI remains more commonly used in clinical practice.